FDA Sanofi - Search News

FDA cancels flu vaccine meeting

FDA cancels pivotal advisory meeting about next season's flu vaccine

An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the delivery schedule.

fingerlakes1 · 4h

FDA abruptly cancels flu vaccine strain selection meeting

Each year, flu vaccines are tailored to match the most prevalent virus strains expected to circulate. Without an official strain selection from the FDA, vaccine makers may be forced to rely solely on recommendations from the World Health Organization (WHO), which is set to meet this Friday.

U.S. News & World Report · 21h

Meeting of US FDA Vaccine Advisers Canceled, Committee Member Says

A meeting of a committee which advises the U.S. Food and Drug Administration on vaccine policy has been canceled, a committee member told Reuters, the second such disruption to a federal vaccine advisory panel since Robert F.

GlobalData on MSN9d

FDA to review Sanofi and Regeneron’s Dupixent sBLA for bullous pemphigoid

Sanofi and Regeneron’s blockbuster biologic Dupixent (dupilumab) is poised for yet another label expansion, this time for the ...

3hon MSN

Health Rounds: Experimental drug delays heart valve disease progression, and potentially surgery

Health Rounds newsletter excerpt has been corrected to indicate in the headline and the first item of the story that Sanofi ...

BioSpace10d

Sanofi Challenges Novo With First FDA Nod for NovoLog Biosimilar

Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...

Sanofi treatment of autoimmune hemolytic anemia granted orphan status

The FDA granted orphan designation to Sanofi ( SNY) US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Published first on TheFly – ...

BioPharma Dive3d

Sanofi, Teva add to case for new bowel disease drug

Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be ...

devdiscourse4h

Breakthrough Heart Drug Ataciguat Shows Promise in Aortic Valve Stenosis Trials

An experimental drug, ataciguat, initially created by Sanofi and further developed by the Mayo Clinic, has significantly ...

ENDPOINTS NEWS3d

Sanofi, Teva bolster case for IBD drug with Phase 2 data, despite potential competition

Sanofi & Teva's IBD drug duvakitug shows promise in Phase 2b with €1B sales potential by 2032, faces competition from Roivant ...

Health Rounds: Experimental Sanofi drug delays heart valve disease progression, and potentially surgery

An experimental drug being developed by Sanofi significantly curbed progression of aortic valve stenosis, a common heart ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results